138 related articles for article (PubMed ID: 15251437)
1. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.
Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J
FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437
[TBL] [Abstract][Full Text] [Related]
2. Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis.
Hwang J; Son KN; Kim CW; Ko J; Na DS; Kwon BS; Gho YS; Kim J
Cytokine; 2005 Jun; 30(5):254-63. PubMed ID: 15927850
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
5. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.
Salcedo R; Young HA; Ponce ML; Ward JM; Kleinman HK; Murphy WJ; Oppenheim JJ
J Immunol; 2001 Jun; 166(12):7571-8. PubMed ID: 11390513
[TBL] [Abstract][Full Text] [Related]
6. Differential CCR1-mediated chemotaxis signaling induced by human CC chemokine HCC-4/CCL16 in HOS cells.
Kim IS; Jang SW; Sung HJ; Lee JS; Ko J
FEBS Lett; 2005 Nov; 579(27):6044-8. PubMed ID: 16226254
[TBL] [Abstract][Full Text] [Related]
7. Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells.
Son KN; Hwang J; Kwon BS; Kim J
Biochem Biophys Res Commun; 2006 Feb; 340(2):498-504. PubMed ID: 16378600
[TBL] [Abstract][Full Text] [Related]
8. The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface.
Hannan NJ; Jones RL; White CA; Salamonsen LA
Biol Reprod; 2006 May; 74(5):896-904. PubMed ID: 16452465
[TBL] [Abstract][Full Text] [Related]
9. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
10. Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15.
Forssmann U; Mägert HJ; Adermann K; Escher SE; Forssmann WG
J Leukoc Biol; 2001 Sep; 70(3):357-66. PubMed ID: 11527984
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of in vitro angiogenic activities of endothelial cells of heterogeneous origin.
Harvey K; Welch Z; Kovala AT; Garcia JG; English D
Microvasc Res; 2002 May; 63(3):316-26. PubMed ID: 11969308
[TBL] [Abstract][Full Text] [Related]
12. Human peripheral blood eosinophils induce angiogenesis.
Puxeddu I; Alian A; Piliponsky AM; Ribatti D; Panet A; Levi-Schaffer F
Int J Biochem Cell Biol; 2005 Mar; 37(3):628-36. PubMed ID: 15618019
[TBL] [Abstract][Full Text] [Related]
13. Increase of expression and activation of chemokine CCL15 in chronic renal failure.
Richter R; Forssmann U; Henschler R; Escher S; Frimpong-Boateng A; Forssmann WG
Biochem Biophys Res Commun; 2006 Jul; 345(4):1504-12. PubMed ID: 16737685
[TBL] [Abstract][Full Text] [Related]
14. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology.
Toda M; Nakamura T; Ohbayashi M; Ikeda Y; Dawson M; Richardson RM; Alban A; Leed B; Miyazaki D; Ono SJ
Novartis Found Symp; 2005; 271():131-40; discussion 140-51. PubMed ID: 16605132
[TBL] [Abstract][Full Text] [Related]
15. Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
Shailubhai K; Dheer S; Picker D; Kaur G; Sausville EA; Jacob GS
J Exp Ther Oncol; 2004 Dec; 4(4):267-79. PubMed ID: 15844657
[TBL] [Abstract][Full Text] [Related]
16. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Salcedo R; Ponce ML; Young HA; Wasserman K; Ward JM; Kleinman HK; Oppenheim JJ; Murphy WJ
Blood; 2000 Jul; 96(1):34-40. PubMed ID: 10891427
[TBL] [Abstract][Full Text] [Related]
17. The 9E3/CEF4 gene product is a chemotactic and angiogenic factor that can initiate the wound-healing cascade in vivo.
Martins-Green M; Feugate JE
Cytokine; 1998 Jul; 10(7):522-35. PubMed ID: 9702416
[TBL] [Abstract][Full Text] [Related]
18. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic activation of alternative CCR1 ligands in inflammation.
Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
